Advertisement

Biodegradable gelatin-based nanospheres as pH-responsive drug delivery systems

  • Manuela Curcio
  • Ilaria Altimari
  • Umile Gianfranco SpizzirriEmail author
  • Giuseppe Cirillo
  • Orazio Vittorio
  • Francesco Puoci
  • Nevio Picci
  • Francesca Iemma
Research Paper

Abstract

Native gelatin, N,N′-ethylenebisacrylamide, and sodium methacrylate were inserted into a spherical crosslinked structure by a solvent-free emulsion polymerization method, in which sunflower seed oil containing different amounts of lecithin was selected as continuous phase. Nanogels were characterized by morphological analysis, particle size distribution, and determination of swelling degree. Different dimensional distributions (100–500 nm) and water affinities were obtained by varying the amount of surfactant in the polymerization feed. Nanogels were non-toxic on human bone marrow mesenchymal stromal cells and enzymatically stable in the gastric tract, with weight losses ranging from 58 to 20 % in pancreatin solution. Release profiles of diclofenac sodium salt from the nanogels were evaluated at different pH and found to depend on crosslinking degree and drug–polymer interactions; while in pancreatin solution, a complete release of the drug was observed. The release mechanism and the diffusional contribution were evaluated by semiempirical equations.

Keywords

Gelatin nanospheres PH-responsive hydrogels Biodegradable Biocompatibility Drug delivery 

Notes

Acknowledgments

This study was financially supported by University of Calabria funds. Financial support of Regional Operative Program (ROP) Calabria ESF 2007/2013—IV Axis Human Capital—Operative Objective M2—Action D.5 is also gratefully acknowledged. Authors thank Dr. Pacini from the Hematology Division, Department of Oncology, Transplants and New Advances in Medicine, University of Pisa, for providing hBM-MSCs.

References

  1. Asif M, Arayne MS, Sultana N, Hussain F (2006) Fabrication of nanoparticles within polymeric pores for controlled release of drug. Pak J Pharm Sci 19:73–84Google Scholar
  2. Carson J, Notis WM, Orris ES (1990) Colonic ulceration and bleeding during diclofenac therapy (I). N Engl J Med 323:135CrossRefGoogle Scholar
  3. Cascone MG, Lazzeri L, Carmignani C, Zhu ZH (2002) Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater M 13:523–526CrossRefGoogle Scholar
  4. Cirillo G, Kraemer K, Fuessel S, Puoci F, Curcio M, Spizzirri UG, Altimari I, Iemma F (2010) Biological activity of a gallic acid-gelatin conjugate. Biomacromolecules 11:3309–3315CrossRefGoogle Scholar
  5. Colombo P, Bettini R, Santi P, Peppas NA (2000) Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today 3:198–204CrossRefGoogle Scholar
  6. Curcio M, Puoci F, Spizzirri UG, Iemma F, Cirillo G, Parisi OI, Picci N (2010a) Negative thermo-responsive microspheres based on hydrolyzed gelatin as drug delivery device. AAPS PharmSciTech 11:652–662CrossRefGoogle Scholar
  7. Curcio M, Spizzirri UG, Iemma F, Puoci F, Cirillo G, Parisi OI, Picci N (2010b) Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release. Eur J Pharm Biopharm 76:48–55CrossRefGoogle Scholar
  8. d’Emanuele A, Dinarvand R (1995) Preparation, characterization, and drug release from thermoresponsive microspheres. Int J Pharm 118:237–242CrossRefGoogle Scholar
  9. Devi N, Maji TK (2010) Microencapsulation of isoniazid in genipin-crosslinked gelatin-A–k-carrageenan polyelectrolyte complex. Drug Dev Ind Pharm 36:56–63CrossRefGoogle Scholar
  10. Dunne M, Corrigan OI, Ramtoola Z (2000) Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21:1659–1668CrossRefGoogle Scholar
  11. Dutta RK, Sahu S (2012) Development of diclofenac sodium loaded magnetic nanocarriers of pectin interacted with chitosan for targeted and sustained drug delivery. Colloids Surf B Biointerfaces 97:19–26CrossRefGoogle Scholar
  12. El-Mahdy M, Ibrahim ES, Safwat S, El-Sayed A, Ohshima H, Makino K, Muramatsu N, Kondo T (1998) Effects of preparation conditions on the monodispersity of albumin microspheres. J Microencapsul 5:661–673CrossRefGoogle Scholar
  13. Friess W (1998) Collagen-biomaterial for drug delivery- review article. Eur J Pharm Biopharm 45:113–134CrossRefGoogle Scholar
  14. Gonçalves C, Pereira P, Gama M (2010) Self-assembled hydrogel nanoparticles for drug delivery applications. Materials 3:1420–1460CrossRefGoogle Scholar
  15. Göpferich A (1996) Mechanism of polymer degradation and erosion. Biomaterials 17:103–114CrossRefGoogle Scholar
  16. Hamidi M, Azadi A, Rafiei P (2006) Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 60:1638–1649CrossRefGoogle Scholar
  17. Hopfenberg HB, Hsu KC (1978) Swelling-controlled, constant rate delivery systems. Polym Eng Sci 18:1186–1191CrossRefGoogle Scholar
  18. Iwanaga K, Yabuta T, Kakemi M, Morimoto K, Tabata Y, Ikada Y (2003) Usefulness of microspheres composed of gelatin with various cross-linking density. J Microencapsul 20:767–776Google Scholar
  19. Li BZ, Wang LJ, Li D, Bhandari B, Li SJ, Lan Y, Chen XD, Mao ZH (2009) Fabrication of starch-based microparticles by an emulsification crosslinking method. J Food Eng 92:250–254CrossRefGoogle Scholar
  20. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Self-assembled hydrogel nanoparticles for drug delivery applications. Adv Drug Deliv Rev 60:1650–1662CrossRefGoogle Scholar
  21. Mano JF (2008) Stimuli-responsive polymeric systems for biomedical applications. Adv Eng Mater 10:515–527Google Scholar
  22. May JE, Morse HR, Xu J, Donaldson C (2012) Development of a novel, physiologically relevant cytotoxicity model: application to the study of chemotherapeutic damage to mesenchymal stromal cells. Toxicol Appl Pharmacol 263:374–389CrossRefGoogle Scholar
  23. Park JH, Ye M, Park K (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10:146–161CrossRefGoogle Scholar
  24. Peniche C, Fernandez M, Gallardo A, Lopez-Bravo A, San Roman J (2003) Systems based on porous chitosan/polyacrylic acid microspheres. Macromol Biosci 3:540–545CrossRefGoogle Scholar
  25. Peppas NA, Sahlin JJ (1989) A simple equation for the description of solute release III. Coupling of diffusion and relaxation. Int J Pharm 57:169–172CrossRefGoogle Scholar
  26. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147CrossRefGoogle Scholar
  27. Ritger PL, Peppas NA (1987) A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5:23–36CrossRefGoogle Scholar
  28. Sahiner N, Singh M (2007) In situ micro/nano-hydrogel synthesis from acrylamide derivates with lecithin organogel system. Polymer 48:2827–2834CrossRefGoogle Scholar
  29. Sairam M, Babu VR, Naidu BVK, Aminabhavi TM (2006) Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles. Int J Pharm 320:131–136CrossRefGoogle Scholar
  30. Schwall CT, Banerjee IA (2009) Micro- and nanoscale hydrogel system for drug delivery and tissue engineering. Materials 2:577–612CrossRefGoogle Scholar
  31. Spizzirri UG, Parisi OI, Iemma F, Cirillo G, Puoci F, Curcio M, Picci N (2010) Antioxidant-polysaccharide conjugates for food application by eco-friendly grafting procedure. Carbohydr Polym 79:333–340CrossRefGoogle Scholar
  32. Spizzirri UG, Iemma F, Altimari I, Curcio M, Puoci F, Picci N (2012) Grafted gelatin microspheres as potential pH-responsive devices. J Mater Sci 47:3648–3657CrossRefGoogle Scholar
  33. Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA (2006) Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. FASEB J 20:542–544Google Scholar
  34. Zhang H, Gao S (2007) Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. Int J Pharm 329:122–128CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Manuela Curcio
    • 1
  • Ilaria Altimari
    • 1
  • Umile Gianfranco Spizzirri
    • 1
    Email author
  • Giuseppe Cirillo
    • 1
  • Orazio Vittorio
    • 2
  • Francesco Puoci
    • 1
  • Nevio Picci
    • 1
  • Francesca Iemma
    • 1
  1. 1.Department of Pharmacy, Health and Nutrition SciencesUniversity of CalabriaRendeItaly
  2. 2.NEST Scuola Normale Superiore, Istituto Nanoscienze-CNRPisaItaly

Personalised recommendations